In one paragraphArticle in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Kourosh EslamiBioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran.
Hajar SirousBioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran. h_sirous@pharm.mui.ac.ir.ORCID 0000-0003-4311-9952 Ilaria CursaroDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.ORCID 0000-0001-7034-3162 Leonardo MilioniDepartment of Medical Biotechnologies, University of Siena, Viale Mario Bracci 16, 53100, Siena, Italy.
Fatemeh ShafieeBioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran.
Gabriele CarulloDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.ORCID 0000-0002-1619-3295 Sandra GemmaDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.ORCID 0000-0002-8313-2417 Sina RajabiBioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran.
Giuseppe CampianiBioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran.ORCID 0000-0001-5295-9529 Simone BrogiBioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran. simone.brogi@unipi.it.ORCID 0000-0001-9375-6242 Funding
Bioinformatics Research Center, Isfahan University of Medical Sciences 240375
6 · The paper itselfAbstract
Lysine-specific demethylase 4 A (KDM4A) is an Fe
Indexed as
Drug DesignEnzyme InhibitorsIsonicotinic AcidsJumonji Domain-Containing Histone DemethylasesCatalytic DomainHumansMolecular Docking SimulationMolecular Dynamics SimulationStructure-Activity RelationshipEnzyme InhibitorsIsonicotinic AcidsJumonji Domain-Containing Histone DemethylasesKDM4A protein, humanEpigeneticsFragment-based designIsonicotinic acid derivativesKDM4A inhibitorsMM-GBSAMolecular dynamics (MD) simulation
What OpenQuestion holds
Textmetadata
Read underepoch 390